Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries.

Shahar ShmuelVirginia PateMarc J PepinJanine C BaileyLaura C HansonTil Stürmer Rebecca B NaumannYvonne M GolightlyDanijela GnjidicJennifer L Lund

Published in: Pharmacoepidemiology and drug safety (2020)

The predictors of high DBI drug exposure can inform discussions between patients and providers about medication appropriateness and potential de-prescribing. Future Medicare-based studies should assess the association between the DBI and adverse events.

Keyphrases

end stage renal disease
adverse drug
ejection fraction
newly diagnosed
chronic kidney disease
primary care
healthcare
peritoneal dialysis
emergency department
drug induced
affordable care act